Valentina Leone

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Maximilian Reichert · 3 shared papers, 2022–2025 · strength 0.63
   • Paper A Pancreatic Cancer Patient-Derived Xenograft Model for Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymp… DOI 10.1016/j.gastha.2022.08.008↗
   • Paper Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response. DOI 10.1038/s44320-025-00085-6↗
   • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
2. Katja Peschke · 1 shared paper, 2022 · strength 0.26
   • Paper A Pancreatic Cancer Patient-Derived Xenograft Model for Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymp… DOI 10.1016/j.gastha.2022.08.008↗
3. Hendrik Schürmann · 1 shared paper, 2025 · strength 0.21
   • Paper Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response. DOI 10.1038/s44320-025-00085-6↗
4. Bernhard Küster · 1 shared paper, 2025 · strength 0.21
   • Paper Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response. DOI 10.1038/s44320-025-00085-6↗
5. Stefanie Höfer · 1 shared paper, 2025 · strength 0.21
   • Paper Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response. DOI 10.1038/s44320-025-00085-6↗
6. Jens Thomas Siveke · 1 shared paper, 2025 · strength 0.21
   • Paper Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response. DOI 10.1038/s44320-025-00085-6↗
7. Marina Lesina · 1 shared paper, 2025 · strength 0.16
   • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
8. Anne T. Schneider · 1 shared paper, 2025 · strength 0.16
   • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
9. Aristeidis Papargyriou · 1 shared paper, 2025 · strength 0.16
   • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
10. Thilo Hackert · 1 shared paper, 2025 · strength 0.16
    • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
11. Henrik Einwächter · 1 shared paper, 2025 · strength 0.16
    • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
12. Matthias M. Gaida · 1 shared paper, 2025 · strength 0.16
    • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
13. Wolfram Trudo Knoefel · 1 shared paper, 2025 · strength 0.16
    • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
14. Roland Michael Schmid · 1 shared paper, 2025 · strength 0.16
    • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
15. Sebastian Mueller · 1 shared paper, 2025 · strength 0.16
    • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
16. Roland Rad · 1 shared paper, 2025 · strength 0.16
    • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
17. Iréne Esposito · 1 shared paper, 2025 · strength 0.16
    • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
18. Tom Luedde · 1 shared paper, 2025 · strength 0.16
    • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗
19. Hana Algül · 1 shared paper, 2025 · strength 0.16
    • Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.